click below
click below
Normal Size Small Size show me how
Day 4a
Part II - Known Teratogenes Drugs
| Question | Answer |
|---|---|
| Methyltestosterone | (Androgens) - 1st Trimester |
| Danazol | (Androgens) - 1st Trimester |
| Nandrolone | (Androgens) - 1st Trimester |
| Oxandrolone | (Androgens) - 1st Trimester |
| Phenytoin | (Anticonvulsants) - 1st Trimester |
| Carbamazepine | (Anticonvulsants) - 1st Trimester |
| Valproic Acid | (Anticonvulsants) - 1st Trimester |
| Phenobarbital | (Anticonvulsants) - 1st Trimester |
| Lamotrigine | (Anticonvulsants) - 1st Trimester |
| What associated primarily with neural tube defects? What to treat? | Anticonsulsants (Carbamazepine and Valproate) - Folic acid 4mg/d |
| Busulfant | (Chemotherapy) 1st Trimester |
| Chlorambucil | (Chemotherapy) 1st Trimester |
| Cyclophosphamide | (Chemotherapy) 1st Trimester |
| Cytarabine | (Chemotherapy) 1st Trimester |
| Methotrexate | (Chemotherapy) 1st Trimester |
| 5-fluorouracil | (Chemotherapy) 1st Trimester |
| cis-retinoic acid | (Chemotherapy) 1st Trimester |
| Lithium | 1st Trimester |
| Associated with cardiac defects (dose related) | Lithium |
| Coumarin derivaties (Warfarin) | 1st, 2nd, and 3rd trimester |
| Spontaneous abortion, stillbirth, neonatal death, cns abnormalities | Warfarin |
| Isotretinoin (Accutane) | (1st trimester) Retinoid derivatives |
| Acitretin (Soriatane) | (1st trimester) Retinoid derivatives |
| Risk of Isotretinoin (Accutane) | Structural abnormalities and Mental retardation |
| HMG CoA reductase inhibitors | (1st trimester) - Structural defectives |
| ACE Inhibots | (2nd and 3rd trimesters) |
| NASIADS | (2nd and 3rd trimesters) |
| Tetracyclines | (2nd and 3rd trimesters) |
| Reduced fetal renal blood flow | ACEi |
| Closure the ductus resulting in pulmonary hepertension | NSAIDS |
| Tooth discoloration and inhibition or bone growth | Tetracyclines |
| Iodine/thyroid medications | All trimesters or period unknown |
| Streptomycin | (All trimesters or period unknown) - Aminoglycosides |
| Kanamycin | (All trimesters or period unknown) - Aminoglycosides |
| Fetal ototoxicity | Aminoglycosides |
| SSRI | (All trimesters or period unknown) |
| Low birth weight and /or respiratory distress | SSRI |
| Misoprostol (cytotec) | (All trimesters or period unknown) - |
| Associated with abortion, congenital malformations, premature labor | Misoprostol (Cytotec) |
| Thalidomide | (All trimesters or period unknown) |
| STEPS program - a high association with structural defects | Thalidomide |
| Ergotamine | (All trimesters or period unknown) - Ergot derivatives |
| Caffergot | (All trimesters or period unknown)- Ergot derivatives |
| Dihydroergotamine | (All trimesters or period unknown)- Ergot derivatives |
| Constric uterine blood vessels thereby affecting placental blood flow = low birth weight | Ergot derivatives |
| Vitamin A | Teratogens with confluict data (<5000 U/d is safe), >25000 = birth defect |
| ASA | Teratogens with confluict data - High dose (>325) |
| Benzodiazepines | Teratogens with confluict data - Hypotonia (ypotonia, hypothermia, respiratory depression) |
| Certain estrogens and progestins | Teratogens with confluict data |
| Beta blockers | Teratogens with confluict data |
| Claravis | (Retinoid Derivatives) - Isotretinoin (Accutaine) -- 1st Trimester |
| Amnesteen | (Retinoid Derivatives) - Isotretinoin (Accutaine) -- 1st Trimester |
| Sotret | (Retinoid Derivatives) - Isotretinoin (Accutaine) -- 1st Trimester |
| Effect during organogenesis | Chemetherapy agents - 1st Trimester |